Evidence map›Paper›PMID 38540977›Full record

ArticleJournal of personalized medicine2024

A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature.

Maria Filoftea Mercuț, Oana Maria Ică, Cornelia Andreea Tănasie, Răzvan Mercuț, Carmen Luminița Mocanu, Andreea Mihaela Nicolcescu, Ciprian Danielescu

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Maria Filoftea MercuțDepartment of Ophthalmology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Oana Maria IcăDepartment of Dermatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Cornelia Andreea TănasieDepartment of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Răzvan MercuțDepartment of Plastic Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Carmen Luminița MocanuDepartment of Ophthalmology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Andreea Mihaela NicolcescuDepartment of Ophthalmology, Clinical County Emergency Hospital, 200642 Craiova, Romania.
Ciprian DanielescuDepartment of Ophthalmology, University of Medicine and Pharmacy Grigorie T. Popa Iasi, 700115 Iasi, Romania.
University of Medicine and Pharmacy of Craiova · ROClinical Emergency Hospital Bucharest · ROGrigore T. Popa University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eales disease manifests as an obliterative periphlebitis affecting the retina; it originates from the periphery and progresses posteriorly. It is characterized by retinal vessel wall inflammation, ischemia, and retinal neovascularization. In this report, we present the case of a 34-year-old male who attended our clinic with a sudden blurring of vision in his right eye. A diagnosis of bilateral retinal vasculitis with vitreal hemorrhage was ascertained in his RE. A dilated ocular fundus examination revealed perivenous sheathing of the peripheral vessels in both eyes. Fluorescein angiography indicated dye staining, vessel obliteration, capillary drop-out, areas of non-perfusion and the formation of new vessels. Laboratory tests revealed positive results for Borrelia; a PPD skin test and QuantiFERON TB assay were also positive. The patient underwent bilateral retinal laser pan-photocoagulation, followed by systemic treatment with oral steroids, cephazoline, isoniazid, azathioprine, and entecavir. The steroid dose was progressively reduced over 10 months; the treatment with azathioprine continues, as we are monitoring the patient over the long term. After 3 months, the vasculitis had regressed without any vitreal hemorrhage recurrence. Vision acuity improved from 0.4 to 1 in the patient's right eye. A multidisciplinary approach, which included collaborative management with gastroenterology, infectious disease, pulmonology, and rheumatology specialists, was essential for the diagnosis, treatment, and long-term follow up of the patient.

Indexed as

Eales diseaseepimacular membraneMycobacterium tuberculosisretinal vasculitis

Identifiers

PMID38540977
PMCPMC10970779
OpenAlexW4392042127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.